News
-
-
-
COMMUNIQUÉ DE PRESSE
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
Prolocor, Inc. announces publication of results from a confirmatory 800 patient ACS trial in JACC, showing a >2-fold predictive value for heart attack, stroke, and death. The Prolocor pFCG® test supports individualized antiplatelet therapy -
-
-
COMMUNIQUÉ DE PRESSE
Prolocor and Slingshot Biosciences Announce Publication of 'Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets' in Bioanalysis
Study in Bioanalysis shows Prolocor pFCG® test as reliable tool for thrombosis risk assessment with TruCytes cell mimics, accurate and precise. Partnership between Prolocor Inc. and Slingshot Biosciences -
-
-
-
